Bayamban, Drixine Grace .

HRN: 11-72-58  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/11/2025
04/12/2025
IVT
500 Mg
X 3 Doses
Thickly MSAF
Waiting Final Action 
04/12/2025
CEFUROXIME 1.5GM (VIAL)
04/12/2025
04/12/2025
IV
1500mg
Every 8 Hours
S/P LTCS
Waiting Final Action 
04/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/12/2025
04/12/2025
IV
500mg
Every 8 Hours
S/P LTCS
Waiting Final Action 
04/12/2025
CEFUROXIME 500MG (TAB)
04/12/2025
04/18/2025
PO
500 Mg
BID
SP LTCS
Waiting Final Action 
04/12/2025
METRONIDAZOLE 500MG (TAB)
04/12/2025
04/19/2025
PO
500
TID
SP LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: